Name: KLOW Blend BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg
Brand: Cyprus Peptides
SKU: CYP-5209
Price: 429.00 USD
Availability: InStock

KLOW Blend at a glance

KLOW is a fixed combination product rather than a new molecule. Each 80 mg vial holds four separately studied peptides: 10 mg BPC-157, 50 mg GHK-Cu, 10 mg TB-500 and 10 mg KPV. The name builds on GLOW, the three-peptide mix without KPV. Because the components keep their own structures, the blend is best described in terms of its parts, and the copper carried by GHK-Cu can give the powder a faint blue color.

Price and availability

A 10mg + 10mg + 50mg + 10mg listing from Cyprus Peptides, shipped from Cyprus. It is listed at $429.00. Funds stay in escrow and are released to Cyprus Peptides only when you mark the order as received.

This listing: Cyprus Peptides KLOW Blend

Brand: Cyprus Peptides
Also sold by: Sulan Bio 80mg $230.00 · Kensington Biosciences 80mg $580.00 · European Peptide Sciences 80mg $750.00 · UWA Biotech 80mg $260.00 · HKTide Biotech 80mg $196.20 · JP 80mg $180.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

What it is studied for

Each component brings its own research profile. BPC-157, a stable fragment derived from a gastric protein, is studied in tendon, gut and blood-vessel models. GHK-Cu, a copper-binding tripeptide, is investigated for effects on collagen production and the expression of genes involved in tissue remodeling. TB-500 regulates actin and is associated with cell migration in repair studies. KPV, a short fragment of alpha-MSH, is examined for dampening inflammatory signaling through the NF-kB pathway. Combining them in one vial does not by itself establish any interaction between them.

Research and regulatory status

There is a preclinical literature for each peptide on its own, covering skin and wound models, gut inflammation, connective tissue and cell culture. The four-way combination, however, has not been studied as a formulation in controlled experiments, so any conclusions about KLOW as a whole are extrapolated from single-agent work. None of the components is an approved medicine for human use, and the blend has no regulatory status beyond research material.

Checking the lab data

A credible KLOW report identifies all four peptides separately. Expect mass spectrometry confirming BPC-157, GHK-Cu, TB-500 and KPV at their expected masses, and an HPLC trace in which each component is resolved and quantified against the stated 10/50/10/10 mg split. A single overall purity number is not enough for a blend. The cake may carry a pale blue tint from the copper complex; dark or patchy discoloration is worth questioning.

This listing has no third-party report on file yet. The lab reports directory and the KLOW Blend page show which brands do publish testing.

Listing details

Compound: KLOW Blend
Synonyms: BPC-157 / GHK-Cu / TB-500 / KPV blend
Class: Four-peptide research blend
Format: Lyophilized (freeze-dried) powder
Vial strength: 10mg + 10mg + 50mg + 10mg
Sold by: Cyprus Peptides
Ships from: Cyprus
Lab report: Not yet published

Storage and preparation

Freeze-dried peptide keeps best sealed, cold and dark. Once it has been dissolved, refrigerate it, avoid repeated warming and follow the stability limits in your study protocol.

Buyer questions

Why would a researcher choose a blend over separate vials?

Mainly convenience and a fixed ratio. A combined vial means one preparation instead of four, and the proportion of each peptide is set by the manufacturer. The trade-off is flexibility: the ratio cannot be adjusted, and if one component degrades or is underfilled, the whole vial is affected, which makes component-level testing important.

Is there research on the four peptides used together?

Not in a controlled, published form that we are aware of. Each peptide has its own preclinical literature, and the blend is a commercial combination of those individually studied materials. Claims that the four work better together are not supported by direct evidence, so the combination should be treated as a convenience format.

What if the parcel never arrives?

Open a claim from your order page. The payment is still in escrow at that point, so a claim decided in your favour is refunded to your Escrow Wallet.

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.